less complexity. more biology. At Chromodynamics, we are on a mission to deliver instruments that eliminate guesswork from drug development and prescription. Our unique technology allows for an enormous improvement in speed, efficacy, and cost with which exciting new treatments like immunotherapy are developed. We have been recognised as one of the most promising startups in the Eindhoven Brainport region and are expanding our team to ramp up our product development. Imaging systems, Multispectral imaging, Real-time analysis, Chemical imaging, Spectroscopy, Scientific instruments, Contract research, and Data analysis

931 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Making healthcare available for every person on earth Microneedle Applicators for Drug Delivery and Biosensing. At uPATCH applicators, we are domain experts in the field of microneedle applicator technology and are dedicated to accelerating the transition of microneedle technology from the lab to real-world applications. Microneedles, which are smaller than 1 mm, provide a revolutionary alternative to traditional injections. They are less painful, carry a reduced risk of infection, and can be easily applied without the need for medical professionals. This makes them ideal for the accessible and efficient administration of drugs and vaccines worldwide. However, one challenge remains largely …

93 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

World leaders, pioneers and advocates in clinically validated, safe and effective #DigitalTherapeutics. We are global pioneers in digital therapeutics, successfully launching our first product in 2001. Our mission is to develop clinically validated digital therapeutics that empower patients, payers, and physicians with effective, FDA cleared products that have the same effect sizes as drugs. Our products are created by our team of multidisciplinary experts, covering all competencies required to develop, launch and maintain top-of-class products for major markets. Our team includes experienced physicians and psychotherapists, clinical scientists experienced in orchestrating Phase II & III trials, IT and software engineers, regulatory …

117 similar entities Type: SMB Activities: healthtech Technologies: Data Analytics

Drugging the Undruggable® PhoreMost is a new-model drug discovery company based in Cambridge, UK. We are dedicated to ‘Drugging the Undruggable®’ disease targets using our next-generation technology, SITESEEKER®. Using PROTEINi® libraries, this unique drug target identification platform can discern the best new targets for future therapy and crucially, how to drug them, which has the potential to significantly increase the diversity and affordability of novel therapeutics for cancer and other unmet diseases. PhoreMost is building a pipeline of novel drug discovery programmes aimed at addressing a range of diseases, with a mission to accelerate, diversify and rationalise drug discovery. Using …

240 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing tomorrow's cancer therapies. Today. invIOs is a private biotech company focusing on discovery and development of novel cancer therapeutics that empower and educate the immune system to fight cancer. We leverage our deep expertise in immune-system activation to advance a focused pipeline of individualized and targeted approaches against solid tumors. Our focus is on earlier-stage development, with a sweet spot in bringing assets through discovery and pre-clinical development and into clinical trials. We launched in 2022 as a spin-out bundling the innovative oncology assets of APEIRON Biologics. Our highly motivated team of 35 people has deep expertise across the …

372 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Cultivating Australian-grown medicines. GMP certified. Built in the Noosa Hinterland in Queensland, PharmaCrop combines international cultivation expertise with Australian production and GMP-certified manufacturing. Our integrated approach brings key stages of cultivation, processing and manufacturing together, supporting quality, consistency and oversight from cultivar selection through to finished product. The result is a growing portfolio of Australian-grown products shaped by global knowledge and pharmaceutical discipline. Pharmaceutical, Retail Pharmacy, Healthcare, Plant Based Medicine, Australian Manufacturing, and Australian Medicinal Cannabis

104 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Transforming Health Care Delivery Everyday 360Medlink Inc. is a software company specialized in healthcare providing validated Digital Health Platforms and Digital Therapeutics (DTx) to optimize patient care and improve access to vulnerable populations. Founded in 2010, the company has been working with the world’s leading pharma/biotech companies and state government (US). Today our products are used by a wide range of clients, across the globe and are deployed in conditions such as cancer, psoriasis, HIV and chronic pain. Our solutions are: 1.TAVIE-Rx: A Digital Medicine to promote patient engagement and adherence. The ideal patient treatment companion for a personalized, culturally …

756 similar entities Type: SMB Activities: healthtech deeptech it services Technologies: Data Analytics

We CARE. We CREATE. We DELIVER. At LTS, our purpose drives everything we do: We CARE for patients, our partners , employees and communities, we CREATE innovative drug delivery solutions, and we DELIVER high-quality products to global markets with an exceptional track record in commercial manufacturing. As a global CDMO, we offer end-to-end development and manufacturing services for pharmaceutical and biotech companies. Our technology portfolio spans transdermal patches, oral thin films, nasal and sterile (drug delivery systems) dosage forms , wearable drug delivery devices as well as microneedle array patches. With over 40 commercial products and 50+ active development programs, …

131 similar entities Type: SMB Activities: deeptech Technologies: Synthetic Biology

Few things are certain in life, but healthy skin will always be in style Cortex Technology – Empowering Skin Professionals for Exceptional Results Cortex Technology is a Danish manufacturer of advanced skin analysis tools and cryotherapy solutions for the medical and aesthetic industries. Since 1985, we have been at the forefront of clinical skin testing and cryosurgical innovation – trusted by dermatologists, aesthetic clinics, researchers, and professionals across the pharmaceutical, biotech, and cosmetics sectors. With nearly 40 years of experience, our mission is clear: to empower professionals by providing precise, user-friendly, and scientifically validated technologies that enhance treatment decisions, improve …

80 similar entities Type: SMB Activities: deeptech biotech

Treating the individual, not just the disease, through personalized and optimized dosing. We need to shift to a world where we treat the individual, not just the disease. Our inventions work in combination with medicine to deliver personalized, optimized dosing, to provide bespoke universal healthcare access and improve outcomes for patients with chronic diseases. Closed Loop Medicine is a TechBio company developing combination prescription drug + software products, with the aim of bringing forward the promise of precision care. Our proprietary technology platform facilitates personalized drug dose optimization through integration of medicines and software with patient-led digital experiences and closed …

85 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Smart Treatment of Diabetes and other Chronic Diseases. Join the needle-free Revolution! MedicSen is a startup founded by young Spaniards with the aim of launching a treatment that will forever change the way we deal with diabetes. They have created an application capable of integrating information from continuous glucose meters with other parameters, entered by the user or collected by smart devices, to offer a record of their glycemic values ​​and give a reliable prediction of future values, thanks to an innovative learning algorithm that communicates with the user through a chat-bot type interface. This provision will provide greater peace …

292 similar entities Tags: H2020 Type: Startup Activities: healthtech deeptech Technologies: Sensors

Let's Build Better Cells Together At MaxCyte®, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation® technology and SeQureTM gene editing risk assessment services enable high-performance cell engineering and rigorous evaluation of editing outcomes, supporting confidence in therapeutic development. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we’ve been advancing cell engineering, shaping …

334 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Transforming research through technology Sophion was founded in the year 2000 by a group of passionate electrophysiologists, all having the shared purpose of making patch clamping objective and independent of user skills to provide faster, more accurate and objective patch clamping results. “To take the voodoo out of patch clamping”. Over the past twenty years, we have developed from a startup into a global organization, but the passion and drive to provide high-performance patch clamp solutions persist. With our complete technical, biological and application support we help our partners to achieve their targets, and through the continued development of our …

66 similar entities Type: SMB Activities: deeptech Technologies: Data Analytics Synthetic Biology

Mereo BioPharma is a clinical-stage company focused on developing & commercialising rare disease & oncology treatments. Welcome to Mereo BioPharma, we are an agile biopharmaceutical company, focused on finding and bringing to market therapies that will improve the lives of people living with a rare disease. We are driven by a true understanding of the critical nature of our mission. We harness the power of science; with our knowledge of the rare diseases we seek to treat and deep relationships with all our stakeholders to create new therapeutic possibilities for people who need them. We do this in a focused …

278 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Medherant is a clinical-stage company developing innovative treatments using its novel transdermal drug delivery technology, the TEPI Patch, which is based on a proprietary adhesive developed by its scientists. The Company was founded by Professor David Haddleton and the University of Warwick in 2015 based on their world-leading expertise in bioadhesives and polymer chemistry. The adhesive has a high drug loading capacity, so a smaller quantity of adhesive is needed to deliver a therapeutic dose; the patch can therefore be thinner and more flexible. It also enables excipients, such as permeation enhancers, to be included in the adhesive so the …

57 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Elevating the health and beauty of life GENEL is an international French biotech company that offers expert multi-disciplinary services to Dermo-Cosmetic, Nutraceutique and Pharmaceutical companies. We support our clients by identifying the right commercial strategy for the successful launch of their product. GENEL for Cosmetics, Dermo and Nutraceutique: Works hand in hand with you to build the unique story of each of your ingredients, and thus elevate the specialty and values of your brand. Thanks to more than 10 years expertise in Skin Homeostasis and in Functional Genomics, we specialize in assisting companies like you that are in the Dermo- …

140 similar entities Type: SMB Activities: deeptech biotech

Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For …

633 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Sharp understanding of the hardest things At Sagacity Health, we discover new horizons in oncology by merging Agentic AI with Biotech to decode the secret world inside tumors - turning unseen ecosystems into the next frontier of precision therapeutics. Our main objective is to bridge groundbreaking science, clinical partnerships, and industrial-scale innovation to bring first-in-class therapies from lab to patient. This is not just drug development; it is a paradigm shift in how we fight cancer.

265 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I.

Solution d'aide au maintien et à la dissimulation des capteurs de prise de glycémie Fabricant Français de patchs dispositifs médicaux d'aide au maintien et à la discrétion des capteurs de glucoses, des pompes à insulines et cathéters. Capteur Protect is a french manufacturer of adhesive solutions for diabetes devices. Our patches are : - Waterproof - Certified Medical Device - Full protection for the duration of the diabetes device - Hypoallergenic Available in different colours : expression or discretion, we got people with diabetes covered. More information at capteurprotect.com

59 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

NanoMedSyn develops a new delivery platform to create first-in-class drugs by the engineering with patented AMFA vectors NanoMedSyn was born from the fundamental research of its biologist and chemist founders who discovered a breakthrough technology for drug delivery to the lysosomal cell compartment leading to potentiation of therapeutics. This technology, validated at the preclinical level, has a wide range of applications in the fields of oncology, immunity, inflammation or metabolism. NanoMedSyn’s development plan is based on a strong intellectual property of patented synthetic derivatives called AMFA. The main application is the engineering of recombinant proteins like antibodies or enzymes for …

175 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

See beyond appearances Damae Medical is reinventing skin imaging, revolutionizing the screening, management, and follow-up of skin cancers (melanoma and carcinoma) with its deepLiveTM solution, which provides an accurate, fast and reliable optical examination without performing a biopsy. CE marked, the deepLiveTM medical device is based on LC-OCT (Line-field Confocal Optical Coherence Tomography) proprietary optical imaging technology that provides 3D images of the different layers of the skin at the cellular level, complemented by several software and Artificial Intelligence (AI) modules. This innovation is protected by 6 patent families and has already been published in more than 100 scientific and …

216 similar entities Type: Startup Activities: healthtech deeptech Technologies: A.I.

The KELTICPharma team combine academic innovation, deep target knowledge and corporate drug discovery expertise. In 2019 Prof Andrew Tobin published validation of PfCLK3 as a target with breakthrough potential in the treatment of malaria. Successful drug development would provide a single medicine that is curative, transmission blocking and prophylactic.

202 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Our vision: To profoundly impact the lives of patients with orphan diseases and their families Orphazyme is a global biopharmaceutical company, headquartered in Denmark, with a rapidly growing presence in the United States. We are pioneering a new kind of treatment, applying our specialized expertise to bring innovative therapies to patients with neurodegenerative orphan diseases. With a late-stage drug pipeline, we are relentless in our commitment to advancing treatments and making a profound impact for those touched by these rare, serious diseases. Today we are listed on Nasdaq Copenhagen (TICKER: ORPHA.CO) and Nasdaq U.S. (TICKER: ORPH), and are expanding our …

443 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Amplio Pharma is a novel and exciting product company developing improved versions of already great drugs. Amplio Pharma is a novel and exciting product company developing improved versions of already great drugs. Amplio Pharma is a privately owned wholly women founded pharmaceutical company. Our vision is to develop and apply modern-day technology to fix the short-comings from drugs that otherwise have a proven track record in their disease area. Our first development candidate, NovoBioJect (AMP101), is being developed to boost the responder rate to current 1st line RA treatment from ca 35% to up to 70%. We intend to reach …

120 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Your strategic one-stop-shop partner. Your device, our care. Selenium Medical is a CDMO fully dedicated to medical devices and pharmaceutical applications. Behind every project lies a shared ambition: improving patients’ quality of life and well-being around the world. Certified to ISO 13485 and registered with the FDA and ANVISA, we support medical device manufacturers and healthcare professionals across the entire value chain, from co-development to market launch, through an integrated and tailored service offering. Our multidisciplinary teams combine technical expertise, regulatory know-how and a strong commitment to quality to deliver solutions tailored to the most complex projects, while ensuring reliability, …

445 similar entities Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

At Orio Therapeutics, our mission is to save lives by making the regenerative medicine dream accessible and a wide-spread reality. We are dedicated to developing novel regenerative drugs with increased efficacy and reduced side-effects, using cutting-edge targeted drug-delivery technologies to create novel therapeutic proteins. Notably, we strive to demonstrate that efficient drug delivery technologies are not confined to the development of complex devices and drug carriers but can be achieved based on clever molecular designs. We aim to initially validate our program pipeline through the development of a therapeutic molecule for myocardial infarction that has the potential to change the …

119 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Transforming science into drug success stories Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​ Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​ We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, …

225 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Making the promise of gene therapy a reality Nanogenics is a UK research based virtual biotechnology company. Founded to develop the LipTideTM nanoformulation platform, the focus now is on developing product ECP105 through preclinical and towards clinical testing. ECP105 is under development for the treatment of Glaucoma patients undergoing trabeculectomy surgery. This surgical technique relieves intra-ocular pressure by creating a channel into which the eye drains. Although well established and successful, surgical failure can occur if the surgical wound undergoes fibrosis and the scar prevents drainage. The active ingredient of ECP105 is an siRNA designed to down-regulate a gene involved …

61 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Building the Future of Precision Medicines through V-Body, RNA and In Vivo Cell Engineering Platforms. At Valerio Therapeutics, we are pioneering a new generation of precision therapies to tackle complex and underserved diseases. Our proprietary V-Body platform is based on two fully synthetic single-domain antibody (sdAb) libraries, derived from a human VH and a fully humanized VHH. Engineered for optimal performance, this ultra-small sdAb platform (~15 kDa) surpasses the limitations of current treatments by enabling deep tissue penetration and highly precise therapeutic delivery, ensuring superior efficacy and target engagement. Our approach integrates innovative target identification using advanced predictive models, antibody …

227 similar entities Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Pyramid studio embodies an unique way of leading therapeutic innovation to fuel the pipeline of pharmaceutical companies Pyramid Studio is a First-of-its-Kind venture builder dedicated to fuel the pipeline of pharmaceutical companies Pyramid Studio embodies a new way of leading therapeutic innovation through a unique build-to-buy model. Our mission is to bridge the gap for pharmaceutical companies seeking access to breakthrough innovations and delivering new therapies to patients. In practice, our team identifies and rigorously selects groundbreaking innovations from top academic teams across Europe. We collaborate closely with our Pharma partners to co-develop and co-finance these programs, ultimately delivering IND-ready …

293 similar entities Type: Incubators & VCs Startup Activities: deeptech biotech Technologies: Synthetic Biology

We create all-in-one instruments that make high-throughput single-cell workflows easy thanks to droplet microfluidics At LiveDrop, we develop, build, and sell cutting-edge instruments and methods for high-throughput screening of biological cells and organisms—down to the single-cell level—using microfluidic droplets. Our solutions enable faster, more precise screenings through highly efficient, fully integrated bioassays. LiveDrop’s flagship platform, ModaFlow 4L5C, revolutionises cell screening, drug discovery, and secretome analysis with unparalleled speed and precision. It supports a wide range of applications, including monoclonal antibody discovery, single-cell secretome-based bioassays, high-throughput spheroid manufacturing for drug testing, directed evolution of microbes, and enzyme discovery. We value collaboration …

343 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Medincell is a pharmaceutical company at commercial stage. We develop a portfolio of long-acting injectables in various therapeutic areas. Our proprietary technology BEPO® aims to ensure patient compliance, improve the effectiveness and accessibility of treatments, and reduce their environmental footprint. We collaborate with tier-one pharmaceutical companies and foundations to improve Global Health through new therapeutic options. Our mission is to contribute to the improvement and protection of the health of populations across the world. The fair sharing of the value created with all our employees is the foundation of our business model. The sustainability of MedinCell is an essential condition …

577 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

"Designs the immunotherapy of tomorrow" At Allogenica, we are transforming cell therapies for a healthier tomorrow. Our mission is to disrupt the treatment landscape for cancer, rare diseases, and autoimmune disorders. We're developing a breakthrough cell therapy platform with the potential to: • Replace transplants: Providing less invasive, accessible alternatives for thousands of patients who currently have limited treatment options. • Expand access for all: With predictable safety and efficacy, we aim to make cell therapies available to a a broader patient population. • Dramatically reduce costs: By streamlining production, we aim to significantly lower the cost of cell therapies, …

178 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

3-D Matrix is a medical device company that offers innovative peptide technology, revolutionising the way healthcare professionals manage oozing bleeding during surgery. Join our community of healthcare professionals: https://www.linkedin.com/groups/12920054/ Headquartered in Tokyo, Japan, 3-D Matrix has expanded across America, Europe, Middle East and Asia. The company collaborates with many researchers, surgeons, healthcare providers and distributors across the world to continually improve on our product. We keep patient outcome at our heart, operating on three main principles: agility, proactiveness and focus. Follow us on Twitter @3dm_emea Sign up to our newsletter for the latest clinical data and product announcements: https://news.3dmatrix.com/newsletter-subscription Medical …

443 similar entities Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

An innovative drug discovery technology Good morning and welcome, we are pleased to introduce you to our structure. AZELEAD has developed ZebraScreen and ZebraTox, an innovative methodology for rapid and accurate assessment of the efficacy and toxicity of a drug In the past few years, we have seen a lot of attrition in the development of new drugs, with a failure rate of nearly 84% attributed to the low benefit of efficacy / toxicity. Three therapeutic areas are mainly affected by this decrease:  oncology (failure rate of 29.5%),  neurology (failure rate of 14%),  and infectious diseases (failure …

283 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Captor Therapeutics is a publicly-listed (WSE:CTX) innovative drug discovery and development company focused on targeting the undruggable proteome using targeted protein degradation. Our mission is to transform lives of patients suffering from cancer, autoimmunity and neurodegenerative diseases. Our groundbreaking technology is perfectly suited to create new drug candidates with the potential to ease patients' burden and cure conditions that so far have only been poorly treatable. Captor Therapeutics S.A. implements projects co-financed by the European Union. All information about the projects is available at: https://captortherapeutics.com/grant-projects. drug development, biotechnology, and protein degradation

734 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Innovators in vaginal drug delivery Calla Lily Clinical Care is a British medical device startup developing Callavid®: a leak-free, convenient and dosage-confident delivery platform for vaginally-delivered drugs. We are initially focused on delivering progesterone for miscarriage prevention and IVF, where there is an unmet need for a patient-friendlier means of drug administration during an already stressful fertility journey. Progesterone prescriptions have significantly increased following the Nov 2021 update to internationally-renowned NICE’s guidance on miscarriages. Callavid® can also deliver menopausal treatments, targeted cancer treatments, and live biotherapeutics (LBPs) cutting antibiotic usage and reducing the spread of antimicrobial resistance (AMR). For pharmaceutical …

81 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

Digital bio-solutions designed to support the development of biomedicines and optimize their prescription. mYXpression is an innovative French company positioned in the field of health innovation. The company, specialized in R&D, develops innovative tools to assist in the prescription of biomedicines. Its first tool, the RITI® RA test, provides a personalized report specific to the patient by indicating an efficacy score for each biotherapy. This brand new approach provides numerous useful insights to the doctor by assisting in the prescription of biotherapy in order to increase the patient's chances of remission. bio-numérique, innovation technologique, big data, bio-technologie , biotherapie, intelligence …

189 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I.

Controlled drug delivery for superior treatment. For patients, worldwide. Controlled drug delivery for superior treatment. For patients, worldwide. AMW’s mission as a specialty pharmaceutical company is to provide patients and our partners with value-added medicines for improved adherence and cost-effective therapies. With our focus on biodegradable controlled-release drug delivery systems suited for almost any indication, we build on our growing development pipeline. Based on our unparalleled expertise in formulation development, we collaborate with pharma and biotech partners worldwide to develop and manufacture high-quality products and life-cycle solutions. We cover the entire value chain, from (co-)development to manufacturing and international commercialization …

83 similar entities Type: Startup Activities: deeptech biotech manufacturing healthtech Technologies: Synthetic Biology

Tailor-designed drug implants ​for local treatments. Founded by Truffle Capital. PK MED is a pioneering French biotechnology company founded in 2019 in Lyon, France, and supported by Truffle Capital, a leading European venture capital firm specializing in life sciences. We develop innovative biodegradable injectable micro-implants and advanced drug delivery technologies designed to address critical healthcare challenges. Our expertise spans rheumatology and novel cell homing approaches aimed at improving the success of bone marrow transplantation. Built on a team of experienced and passionate experts in pharmaceutical sciences, drug delivery, and biomaterials engineering, PK MED combines scientific excellence with innovation to develop …

98 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Delivery of vision care EyeD Pharma is a clinical stage pharmaceutical company dedicated to improving the life of patients suffering from ophthalmic diseases with unmet medical needs such as glaucoma or dry eye. We develop innovative therapeutic solutions based on sustained release polymeric micro-implants and inserts.

127 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology

616 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Crafting next generation of small molecule anti-parasitic drugs by harnessing comparative structural data At ASTRA Therapeutics, we are redefining parasite drug development by leveraging the specificity of ParabulinsTM. Our mission is clear: to lead the fight against parasitic diseases with precision-engineered solutions.

77 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

"Treating Tumors from the Inside" - Intra-tumoral delivery of oncology drugs OncoLize (NL) develops intra-tumoral drug depots to "Treat Tumors from the Inside". This means clinicians can inject and keep certain drugs where they are most effective: inside the tumor mass. Our patent protected ChemoGell(TM) platform is based on hydrogel technology, an awesome injectable drug depot platform developed at RCSI, Dublin by prof.dr. Helena Kelly and her team. We have an exclusive, world wide license for oncology. The base-patents have recently been granted in US, EU, China and Japan, with more in the pipeline. With the Gastro-Oncology team at Leiden …

199 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Multi-target cell and gene therapies for unmet medical needs. Aurealis Therapeutics is a Swiss-Finnish Cell and Gene Therapy Platform Company. Our multi-target cell and gene therapies, based on genetically modified safe lactic acid bacteria, address unmet medical needs: Chronic Wounds - Diabetic Foot Ulcers, Venous Ulcers, Pressure Ulcers - deadly Cancers - Ovarian Cancer, Peritoneal Carcinomatosis - Inflammatory diseases. After successfully completing Phase 1 and Phase 2 clinical studies in Diabetic Foot Ulcer (DFU) with our lead asset AUP-16, we're actively preparing a global DFU Phase 3 study. Other indications will follow In Oncology, we are building on impressive pre-clinical …

193 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

La sfida che ci proponiamo è quella di rivoluzionare completamente l'approccio terapeutico nel campo oftalmico. The hard clinical context related to the age-related macular degeneration or maculopathy, chronic ocular disease and first cause of blindness in developed countries, has to be solved. The number of affected patients is increasing drastically with 500'000 new cases per year and a pool of 260 million patients is estimated for 2040. Despite the noted efficacy of the drug, the intravitreal injections to which patients are subjected monthly implies a high rate of treatment dropout, followed by a very high risk of irreversible blindness condition. …

128 similar entities Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

We develop, optimise and distribute innovative pharmaceutical products that offer a unique solution Who we are: Green Park Pharma UK Ltd. is a pharmaceutical company specialising in innovative drug delivery formulations. Our products address a significant market need across major global markets where the team has successfully operated. Our mission: Our mission is to develop, optimise and distribute innovative pharmaceutical products that offer a unique solution for unmet patient needs across all major global markets. Learn more about us and get in touch

282 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Science for cure. NEOGAP Therapeutics AB is a privately held clinical stage biopharmaceutical company with the main focus on immuno-oncology. The company was founded in 2016 by Dr. Hans Grönlund. We are located at Therapeutic Immune Design, Centre for Molecular Medicine at Karolinska Institute, Stockholm, Sweden. Our vision is to increase overall survival among patients with cancer by boosting tumour-specific responses of the immune system. Our mission is to become an important player in the battle against cancer by development and commercialisation of our innovative cancer immunotherapy. Biopharmaceutical company, Immunotherapy, and Immuno-oncology

299 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

UroGen Pharma is a biotech company that builds novel solutions to revolutionize the way specialty cancers and urologic diseases are treated – because patients deserve better options. Our vision is grounded in our RTGel® drug delivery technology, our promising pipeline, and a collaborative drive for bold results. Our existing technology: the RTGel drug delivery technology has the potential to be applied to a variety of unmet medical needs. RTGel reverse-thermal hydrogel is liquid at lower temperatures and converts to gel form at body temperature, offering the opportunity to make local therapy a more effective treatment. Our promising pipeline: Ranging from …

79 similar entities Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Enabling MedTech Innovation Combining technical expertise, advanced materials and custom engineered processes to help innovators overcome complex challenges and turn bold ideas into manufacturable, scalable and successful medical devices. From precision converting to complete device assembly, we operate as an extension of your team. By bringing together process engineering, material science and manufacturing capability, we accelerate your journey from concept to commercial reality. Get in touch : enquiries@polarseal.net Wound Dressing, Fixation Devices , Surgical Devices, Ostomy Devices , DIagnostics, Consumer Health Care, Electro - Medical Products , Biomedical Products , Wearable Devices, and Tape converter

330 similar entities Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

Collaborating with NIH & DoD to develop treatment options, targeting unmet needs in three multi-billion dollar markets. Virpax is pioneering advanced healthcare solutions with Probudur, its flagship product leveraging proprietary liposomal encapsulation. Designed for sustained release, Probudur delivers local anesthetic at the wound/incision site, effectively managing post-operative pain for an extended 96 hours. Collaborating through Cooperative Research and Development Agreements (CRADA) and partnering with prestigious institutions like the National Institute of Health/NCATS and U.S. Army Institute of Surgical Research/Department of Defense, we are committed to developing non-addictive treatments. Additionally, our involvement in the Epilepsy Therapy Screening Program (ETSP) underscores our …

145 similar entities Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology

The natural solution for drug delivery DelSiTech is a drug delivery and drug development company based in Turku, Finland. DelSiTech has developed a unique proprietary technology making it a world leader in advanced biodegradable silica-based drug delivery. The technology has successfully been applied to the controlled release of small molecules, biopharmaceuticals and viral vectors with a focus on parenteral and local administration. We can work with you from early feasibility testing to clinical proof of concept; the technology can also be licensed to industry partners. With the DelSiTechTMSilica Matrix, we can create novel products, provide alternative administration opportunities, and extend …

86 similar entities Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology

At FairJourney Bio, we specialize in cutting-edge antibody discovery and development, offering end-to-end solutions that fast-track your research. With over a decade of expertise, our innovative technologies and seasoned team have successfully advanced 19 antibodies to clinical stages. Our adaptable partnership model empowers projects of any scale, fostering collaboration and breakthrough innovation. Whether you're in early-stage research or development, we deliver tailored, high-quality antibodies designed to meet your specific needs. Join us in revolutionizing therapeutic discovery and making lasting impacts on global healthcare. Monoclonal antibodies, Antibody humanization, Antibody production, Antibody affinity maturation, Phage display libraries, Mammalian Display, Naïve Libraries, VHH …

193 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Tackling the toughest cancers. We’re OxSonics, a pioneering clinical-stage medical device company committed to developing a ground-breaking platform technology to deliver anti-cancer drugs so they can act smarter, act faster and, above all, work better. Our SonoTran® Platform has been designed to actively enhance the delivery of oncology drugs into solid tumours. SonoTran® is drug agnostic and requires no drug reformulation enabling its use with both existing and novel therapies. We have our own development programs as well as collaborations with Pharmaceutical and biotech companies to work to bring smarter, faster and better therapies to as many patient groups as …

192 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Improving anaphylaxis management Adan Medical Innovation is a company focused on the improvement of the quality of life of patients that suffer from anaphylaxis, a severe allergic reaction. To achieve this, we have formed a group of experts in different fields (physicians specialized in Allergy and Internal Medicine, business development, patent and regulatory health technologies issues, engineers, information technologies), even including patients among us, and we are working together to offer the best solutions for these patients. The company has developed integrated digital solutions to improve the management of anaphylaxis, having nowadays two different products in its pipeline: AnAPPhylaxis, a …

224 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

Bringing Advanced, Smart and Light-driven therapy for skin pathologies to patients around the world KHOTT BIOTECH | Translating Cutting-Edge Science into Transformative Healthcare Solutions At KHOTT BIOTECH, we are driven by a simple yet powerful mission: to bridge the gap between breakthrough science and real-world patient impact. Specialising in advanced therapeutic and wound-care technologies, we develop innovative solutions that address unmet clinical needs while prioritising safety, efficacy and patient quality of life. Our flagship platform, PDPatch, leverages dual-action photodynamic therapy to accelerate wound healing, combining rigorous research with practical, scalable applications. By integrating biomedical research, pre-clinical development, and strategic collaborations, …

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

info@healometx.com Healome Therapeutics is an eye care therapeutics company developing more effective, safer, and practical treatments for vision-threatening ocular surface conditions. Using our eye drop matrix technology, we aim to engineer and deliver microenvironments that encourage healing of the eye and improve the therapeutic effect of new and existing eye medicines. We strive to raise the standard of care in disease management, addressing root causes of disease, and healing of the damage left behind. In doing so, we aim to support healthcare providers and patients to achieve the best possible clinical outcome.

112 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital TherapeuticsTM, we deliver accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Our treatments are defined by our commitment to applying technical and scientific rigor and patient-centric design to the development process. This results in uniquely engaging experiences that achieve compelling clinical outcomes for patients seeking new treatment options. We are continuously expanding and refining our shared platform technologies with novel cognitive, behavioral and neuromodulatory mechanisms of action and advanced data-driven tools such …

152 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: A.I. - Machine Learning

Delivering powdered, needle-free vaccines Orlance, Inc. is a Seattle-based biotech company developing the MACH-1TM platform of precise and localized powdered vaccines and immunotherapies for multiple indications including influenza, fungal diseases, and various cancers. The lead MACH-1 asset, a universal influenza vaccine, is targeted to enter Phase 1 trials in early 2027. MACH-1 needle-free vaccines and immunotherapies are powdered, low-dose, and shelf-stable nucleic acid formulations delivered pneumatically into the epidermis, the outermost active layer of skin. MACH-1’s epidermal targeting uniquely produces immediate and highly-localized dosing, generating both systemic antibody and T-cell and mucosal T-cell immunity.

60 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology SaaS

Developing life-changing, innovative therapies for diseases with unmet needs Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics. Intranasal Drug Delivery, Migraine, Parkinson's Disease, CNS Therapeutics, and Autism

238 similar entities Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

The leader in Prescription Digital Therapeutics Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to redefine care through the widespread use of clinically validated software-based therapeutics to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. Pear has the first end-to-end platform to discover, develop, and deliver PDTs to patients and a pipeline of products and product candidates across therapeutic areas, including the first …

59 similar entities Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Allogeneic Cell Therapy Platform that Leverages Natural Platelet Biology PlateletBio is an allogeneic cell therapy company focused on platelet biology. We are pioneers, discovering a new category in therapeutics. Our approach is one-of-a-kind, recreating nature’s legendary delivery cell. In doing so, we’re developing a cell therapy empowered to tackle previously unmet medical challenges. biotechnology, platelets, and drug discovery

459 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Unlock the potential of your drug with our expertise in Transdermal and complex Injectable product development Nemaura Pharma is a private specialist biotech company who have developed several advanced versatile skin drug delivery systems. Our technologies have been designed with clinical needs in mind and are all minimally invasive and very cost-effective. We are strategically positioned to work with global pharmaceutical companies, as well as new biotechnology companies, to successfully bring both new and old drugs to patients in superior delivery formulations and systems. Founded in 2005 Nemaura has its headquarters and laboratory facilities in the United Kingdom at the …

172 similar entities Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology